missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Everolimus, MedChemExpress
Description
Everolimus (RAD001) is a Rapamycin (HY-10219) derivative and a potent, selective and orally active mTOR1 inhibitor. Everolimus binds to FKBP-12 to generate an immunosuppressive complex. Everolimus inhibits tumor cells proliferation and induces cell apoptosis and autophagy. Everolimus has potent immunosuppressive and anticancer activities.
Specifications
Specifications
| Chemical Name or Material | Everolimus |
| Physical Form | Powder |
| CAS | 159351-69-6 |
| Color | White |
| Quantity | 100 mg |
| Purity Grade Notes | Research |
| Molecular Formula | C53H83NO14 |
| For Use With (Application) | Cancer-Kinase/protease |
| Synonym | RAD001 SDZ-RAD |
| Solubility Information | DMSO : ≥ 54 mg/mL (56.35 mM) ∣H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble) |
| Show More |
Research purposes only
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?